Axbio (Anxuyuan Biotechnology)

Axbio is a semiconductor-biotechnology company that integrates integrated circuits (IC), biotechnology (BT), and artificial intelligence (AI) to develop next-generation life science tools. The company specializes in nanopore sequencing, Bio-CMOS chip design, and electrochemical sensing platforms for high-throughput sequencing and molecular diagnostics. Founded in 2016, the company operates R&D centers across the United States, China, and Europe. Its technology platform enables a range of applications from handheld bedside diagnostic devices to fully automated laboratory instruments, targeting fields such as early cancer screening, rapid pathogen detection, and drug development.